21st Century Cancer Research & Dr. Clay Siegall

Cancer comes in many forms, and it affects the organs of the body such as the lungs, the colon, the prostate and the breast. This illness is feared by many because of its complexity. One of the best ways for dealing with cancer is early diagnosis. Some forms of cancer grow at a slow rate while other forms grow more rapidly. Cancer research has given society a better understanding about this deadly disease and Seattle Genetics just so happens to be one of those institutions. This oncology biotech company has been around since the late 1990s, and it has helped to revolutionize cancer research.

Dr. Clay Siegall is the founder, the president and the chief executive officer here. This extraordinary man is one of the most well-accomplished professionals in the world, especially when it comes to this specific field of work. He has worked with some of the biggest organizations in the business including the National Institute of Health, the National Cancer Institute and Bristol-Myers Squibb. The world of cancer research has made astounding gains in genetic testing, which has resulted in a reduced cost in genetic-sequencing. A person’s DNA code is made-up of an estimated 20,000 genes and every person’s DNA code is different from the next person. This gives cancer researchers a better understanding to why the disease affects each person in different ways. Thanks to the advancements, extracting the DNA code is possible and a person’s genetics can predispose him or her to certain forms of cancer.

Research also shows that the environment and your diet can play a critical factor in developing certain illnesses like cancer. Dr. Siegall knows this all too well because he has experienced the devastating effects of cancer via a family member. He has vowed to make cancer research his life’s work and as of today, he has done a wonderful job by bringing new advancements to the forefront.

Clay Siegall and His Innovation for Cancer Treatments

In the year 2013, Mirna Therapeutics announced to the world that Clay Siegel would be the newly appointed Board of Directors. Clay Siegall was formerly the Chairman Board of Directors and Chief Executive Director of the company Seattle Genetics. Clay Siegall was the founder of Seattle Genetics where he created a successful anti – body treatment for patients with cancer. Siegall is highly educated in the field. He has published over 70 works as well as holding 15 patents.

Seattle Genetics Co-Founder Appointed to Board of Directors for Mirna Therapeutics Inc.

Seattle Genetics
Clay Siegall is the CEO of Seattle Genetics which is a company that is concentrated on finding breakthroughs within the anti-body based therapies that are used when treating cancer. Seattle Genetics is the top leader in creating anti-body drug conjugates,otherwise known as ADCs. ADCs are so important to the research of the company because they are used to reduce the harm that can be done by traditional chemotherapy. The company is working day in and day out to create better systems for health needs that are not being met by patients.

The company is built on a set of concrete values that continue the positive growth of the company. Some of these values include a passion for the improvement of patients, integrity when dealing with patients, scientific excellence, and and innovative approach to creating new treatement.
Clay Siegall
Clay Siegall has been trained in the field of science, while focusing on different types of cancer therapies. Siegall created Seattle Genetics with the hope that the company would find more innovative, and effective, methods when treating patients with cancer. The company has done this under the leadership of Siegall by doing large amounts of research, as well as practices that look out for the well being of every patient. Because of his development of quality products, the company has produced treatments that are able to be sold in over 60 countries. He has entered into different licenses that have made over 325 million dollars.